Reporting owner · Q3 2026 · CIK 1578850

Almstead Neil Gregory: insider trades.

Almstead Neil Gregory reported 14 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 9 sales ($4.3M), across 1 company.

Transactions
14
Purchases (P)
0
Sales (S)
9
Companies
1
Name as filed
Almstead Neil Gregory

Companies

CompanyRelationshipTransactions
Ptc Therapeutics, Inc. (PTCT)Officer · CHIEF TECHNICAL OPS OFFICER14

Transactions

14 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-07-09Ptc Therapeutics, Inc.S2,464$90.2560,299Form 4
2026-07-09Ptc Therapeutics, Inc.M2,464$46.5462,763Form 4
2026-07-07Ptc Therapeutics, Inc.S9,288$89.4460,299Form 4
2026-07-07Ptc Therapeutics, Inc.S11,369$89.0369,587Form 4
2026-07-07Ptc Therapeutics, Inc.S3,956$87.1780,956Form 4
2026-07-07Ptc Therapeutics, Inc.M24,613$39.4284,912Form 4
2026-07-06Ptc Therapeutics, Inc.S385$86.3460,299Form 4
2026-07-06Ptc Therapeutics, Inc.S426$85.2860,684Form 4
2026-07-06Ptc Therapeutics, Inc.M811$38.161,110Form 4
2026-07-06Ptc Therapeutics, Inc.S2,474$87.0360,299Form 4
2026-07-06Ptc Therapeutics, Inc.M2,474$39.4262,773Form 4
2026-07-06Ptc Therapeutics, Inc.M18,876$38.179,175Form 4
2026-07-06Ptc Therapeutics, Inc.S8,786$85.3570,389Form 4
2026-07-06Ptc Therapeutics, Inc.S10,090$86.3260,299Form 4

Questions

What stock did Almstead Neil Gregory buy or sell?

Almstead Neil Gregory reported 14 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 9 sales ($4.3M), across 1 company.

Is Almstead Neil Gregory the same person as other filers with this name?

This page covers SEC CIK 1578850 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/almstead-neil-gregory-1578850.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.